Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

SEC Filing · DEFA14A

Accuray Incorporated

ARAYNASDAQEQUITYCurrent

SEC Filing

Filed Sep 18, 2026Accepted Sep 18, 2026, 4:05 PM EDTCIK 1138723Accession 0001140361-26-037108
Share

Company context

Accuray is committed to expanding the powerful potential of radiation therapy to improve as many lives as possible. We invent unique, market-changing solutions designed to deliver radiation treatments for even the most complex cases - while making commonly treatable cases even easier - to meet the full spectrum of patient needs. We are dedicated to continuous innovation in radiation therapy for oncology, neuro-radiosurgery, and beyond, as we partner with clinicians and administrators, empowering them to help patients get back to their lives, faster. Accuray is headquartered in Madison, Wisconsin, with facilities worldwide. To learn more, visit www.accuray.com or follow us on Facebook, LinkedIn, X, and YouTube.

Current securities

Recent company filings

  1. EFFECT filingSep 11, 2026
  2. 424B3 filingSep 11, 2026
  3. S-3/A filingSep 9, 2026
  4. 4 filingSep 2, 2026
  5. 10-K filingAug 27, 2026

As-filed source

Primary evidence